Revvity, 3044-001U, NeoBase 2 Non-derivatized MSMS kit

Overview
The next generation in tandem mass spectrometry based newborn screening, the NeoBase™ 2 Non-derivatized MSMS kit gives you the ability to screen for all the common acid, organic acid and fatty acid oxidation.

For more than 50 analytes, including markers for screening of x-ald and ada scid, from a single DBS punch with a single extraction and incubation step.
A reformulated flow solvent that improves ionization and makes it easy to switch between the NeoLSD™ kit and NeoBase™ 2 kit
DBS quality controls with analyte concentrations adjusted at clinically significant levels
All internal standards are in a single vial making reconstitution easy. Extraction solution is stable for up to two weeks, eliminating the need for daily preparation.
Shorter extraction time, shorter incubation time and shorter run time
New specific markers for urea cycle disorders asa-ld, otcd, cps-i and nags as well as for ADA SCID providing more conclusive screening results Application-Newborn Screening
Brand-NeoBase™ 2
Detection Modality-Mass Spectrometry (MSMS)
Disorders-Metabolic Disorders
Instrument Compatibility-QSight
Sample Type-Dried blood spots
Technology-Mass Spectrometry
Unit Size-1 kit